1. Home
  2. TOPP vs LGVN Comparison

TOPP vs LGVN Comparison

Compare TOPP & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOPP
  • LGVN
  • Stock Information
  • Founded
  • TOPP 2014
  • LGVN 2014
  • Country
  • TOPP United States
  • LGVN United States
  • Employees
  • TOPP N/A
  • LGVN N/A
  • Industry
  • TOPP
  • LGVN Medicinal Chemicals and Botanical Products
  • Sector
  • TOPP
  • LGVN Health Care
  • Exchange
  • TOPP NYSE
  • LGVN Nasdaq
  • Market Cap
  • TOPP 23.1M
  • LGVN 23.4M
  • IPO Year
  • TOPP 2025
  • LGVN 2021
  • Fundamental
  • Price
  • TOPP $1.72
  • LGVN $1.35
  • Analyst Decision
  • TOPP
  • LGVN Strong Buy
  • Analyst Count
  • TOPP 0
  • LGVN 3
  • Target Price
  • TOPP N/A
  • LGVN $8.67
  • AVG Volume (30 Days)
  • TOPP 155.3K
  • LGVN 126.3K
  • Earning Date
  • TOPP 01-01-0001
  • LGVN 05-08-2025
  • Dividend Yield
  • TOPP N/A
  • LGVN N/A
  • EPS Growth
  • TOPP N/A
  • LGVN N/A
  • EPS
  • TOPP 0.01
  • LGVN N/A
  • Revenue
  • TOPP $16,039,513.00
  • LGVN $2,225,000.00
  • Revenue This Year
  • TOPP N/A
  • LGVN $1.30
  • Revenue Next Year
  • TOPP N/A
  • LGVN $19.15
  • P/E Ratio
  • TOPP $144.11
  • LGVN N/A
  • Revenue Growth
  • TOPP N/A
  • LGVN 127.50
  • 52 Week Low
  • TOPP $0.97
  • LGVN $0.77
  • 52 Week High
  • TOPP $4.50
  • LGVN $6.40
  • Technical
  • Relative Strength Index (RSI)
  • TOPP N/A
  • LGVN 40.87
  • Support Level
  • TOPP N/A
  • LGVN $1.30
  • Resistance Level
  • TOPP N/A
  • LGVN $1.52
  • Average True Range (ATR)
  • TOPP 0.00
  • LGVN 0.13
  • MACD
  • TOPP 0.00
  • LGVN -0.02
  • Stochastic Oscillator
  • TOPP 0.00
  • LGVN 9.43

About TOPP TOPPOINT HOLDINGS INC

Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: